Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 19535783)

1.

Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.

Marzese DM, Hoon DS.

Expert Rev Mol Diagn. 2015 May;15(5):647-64. doi: 10.1586/14737159.2015.1027194. Epub 2015 Mar 22.

PMID:
25797072
2.

NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.

Chu D, Zhang Z, Zhou Y, Li Y, Zhu S, Zhang J, Zhao Q, Ji G, Wang W, Zheng J.

Oncotarget. 2015 Apr 10;6(10):7584-96.

3.

Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.

Xiao W, Zhao H, Dong W, Li Q, Zhu J, Li G, Zhang S, Ye M.

Oncol Lett. 2015 Mar;9(3):1383-1387. Epub 2014 Dec 19.

4.

Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.

Ng JM, Yu J.

Int J Mol Sci. 2015 Jan 22;16(2):2472-96. doi: 10.3390/ijms16022472.

5.

DNA Methylation and Colorectal Cancer.

Ashktorab H, Brim H.

Curr Colorectal Cancer Rep. 2014 Dec 1;10(4):425-430.

PMID:
25580099
6.

Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.

Melotte V, Yi JM, Lentjes MH, Smits KM, Van Neste L, Niessen HE, Wouters KA, Louwagie J, Schuebel KE, Herman JG, Baylin SB, van Criekinge W, Meijer GA, Ahuja N, van Engeland M.

Cancer Prev Res (Phila). 2015 Feb;8(2):157-64. doi: 10.1158/1940-6207.CAPR-14-0198. Epub 2014 Dec 23.

7.

Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.

Zhang H, Qi J, Wu YQ, Zhang P, Jiang J, Wang QX, Zhu YQ.

World J Gastroenterol. 2014 Oct 14;20(38):14040-50. doi: 10.3748/wjg.v20.i38.14040. Review.

8.

Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection.

Mansour H.

Front Genet. 2014 Aug 27;5:182. doi: 10.3389/fgene.2014.00182. eCollection 2014. Review.

9.

DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA.

Lu H, Huang S, Zhang X, Wang D, Zhang X, Yuan X, Zhang Q, Huang Z.

Oncol Lett. 2014 Oct;8(4):1751-1756. Epub 2014 Aug 4.

10.

DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Toiyama Y, Okugawa Y, Goel A.

Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):43-57. doi: 10.1016/j.bbrc.2014.08.001. Epub 2014 Aug 13. Review.

PMID:
25128828
11.

Advances in epigenetic biomarker research in colorectal cancer.

Wang X, Kuang YY, Hu XT.

World J Gastroenterol. 2014 Apr 21;20(15):4276-87. doi: 10.3748/wjg.v20.i15.4276. Review.

12.

LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.

Liu WB, Jiang X, Han F, Li YH, Chen HQ, Liu Y, Cao J, Liu JY.

Cell Death Dis. 2013 Oct 24;4:e882. doi: 10.1038/cddis.2013.366.

13.

Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.

Lee JH, Kim KH, Park JW, Chang HJ, Kim BC, Kim SY, Kim KG, Lee ES, Kim DY, Oh JH, Yoo BC, Kim IH.

Int J Cancer. 2014 Apr 15;134(8):1844-53. doi: 10.1002/ijc.28517. Epub 2013 Oct 21.

14.

Novel methylation biomarker panel for the early detection of pancreatic cancer.

Yi JM, Guzzetta AA, Bailey VJ, Downing SR, Van Neste L, Chiappinelli KB, Keeley BP, Stark A, Herrera A, Wolfgang C, Pappou EP, Iacobuzio-Donahue CA, Goggins MG, Herman JG, Wang TH, Baylin SB, Ahuja N.

Clin Cancer Res. 2013 Dec 1;19(23):6544-55. doi: 10.1158/1078-0432.CCR-12-3224. Epub 2013 Oct 2.

15.

Bves and NDRG4 regulate directional epicardial cell migration through autocrine extracellular matrix deposition.

Benesh EC, Miller PM, Pfaltzgraff ER, Grega-Larson NE, Hager HA, Sung BH, Qu X, Baldwin HS, Weaver AM, Bader DM.

Mol Biol Cell. 2013 Nov;24(22):3496-510. doi: 10.1091/mbc.E12-07-0539. Epub 2013 Sep 18.

16.

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection.

Ma Y, Wang X, Jin H.

Int J Mol Sci. 2013 May 16;14(5):10307-31. doi: 10.3390/ijms140510307.

17.

Whole-exome sequencing studies of nonfunctioning pituitary adenomas.

Newey PJ, Nesbit MA, Rimmer AJ, Head RA, Gorvin CM, Attar M, Gregory L, Wass JA, Buck D, Karavitaki N, Grossman AB, McVean G, Ansorge O, Thakker RV.

J Clin Endocrinol Metab. 2013 Apr;98(4):E796-800. doi: 10.1210/jc.2012-4028. Epub 2013 Feb 28.

18.

Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer.

Zhang H, Song YC, Dang CX.

Int J Med Sci. 2013;10(3):230-4. doi: 10.7150/ijms.5278. Epub 2013 Jan 13.

19.

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Kisiel JB, Yab TC, Nazer Hussain FT, Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk TC, Itzkowitz SH, Rubin DT, Zou H, Mahoney DW, Ahlquist DA.

Aliment Pharmacol Ther. 2013 Mar;37(5):546-54. doi: 10.1111/apt.12218. Epub 2013 Jan 24.

20.

A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors.

Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE.

Clin Transl Gastroenterol. 2012 Dec 6;3:e27. doi: 10.1038/ctg.2012.21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk